Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 146

1.

Derivation of Macrophages from Mouse Bone Marrow.

Davis BK.

Methods Mol Biol. 2019;1960:41-55. doi: 10.1007/978-1-4939-9167-9_3.

PMID:
30798519
2.

The Scaffolding Protein IQGAP1 Interacts with NLRC3 and Inhibits Type I IFN Production.

Tocker AM, Durocher E, Jacob KD, Trieschman KE, Talento SM, Rechnitzer AA, Roberts DM, Davis BK.

J Immunol. 2017 Oct 15;199(8):2896-2909. doi: 10.4049/jimmunol.1601370. Epub 2017 Sep 1.

3.

Maxillofacial prosthetics training and practice profiles in the United States.

Sheets JL, Yuan JC, Sukotjo C, Davis BK, Wee AG.

J Prosthet Dent. 2017 Oct;118(4):540-545. doi: 10.1016/j.prosdent.2016.12.020. Epub 2017 Mar 23.

PMID:
28343678
4.

The Poly(ADP-ribose) Polymerase Enzyme Tankyrase Antagonizes Activity of the β-Catenin Destruction Complex through ADP-ribosylation of Axin and APC2.

Croy HE, Fuller CN, Giannotti J, Robinson P, Foley AV, Yamulla RJ, Cosgriff S, Greaves BD, von Kleeck RA, An HH, Powers CM, Tran JK, Tocker AM, Jacob KD, Davis BK, Roberts DM.

J Biol Chem. 2016 Jun 10;291(24):12747-60. doi: 10.1074/jbc.M115.705442. Epub 2016 Apr 11.

5.

Inflammasome-independent role of AIM2 in suppressing colon tumorigenesis via DNA-PK and Akt.

Wilson JE, Petrucelli AS, Chen L, Koblansky AA, Truax AD, Oyama Y, Rogers AB, Brickey WJ, Wang Y, Schneider M, Mühlbauer M, Chou WC, Barker BR, Jobin C, Allbritton NL, Ramsden DA, Davis BK, Ting JP.

Nat Med. 2015 Aug;21(8):906-13. doi: 10.1038/nm.3908. Epub 2015 Jun 24.

6.

Emerging significance of NLRs in inflammatory bowel disease.

Davis BK, Philipson C, Hontecillas R, Eden K, Bassaganya-Riera J, Allen IC.

Inflamm Bowel Dis. 2014 Dec;20(12):2412-32. doi: 10.1097/MIB.0000000000000151. Review.

7.

Evaluation of classical, alternative, and regulatory functions of bone marrow-derived macrophages.

Davis BK.

Methods Mol Biol. 2013;1032:79-89. doi: 10.1007/978-1-62703-496-8_6.

PMID:
23943445
8.

Isolation, culture, and functional evaluation of bone marrow-derived macrophages.

Davis BK.

Methods Mol Biol. 2013;1031:27-35. doi: 10.1007/978-1-62703-481-4_3.

PMID:
23824883
9.

Type I IFN triggers RIG-I/TLR3/NLRP3-dependent inflammasome activation in influenza A virus infected cells.

Pothlichet J, Meunier I, Davis BK, Ting JP, Skamene E, von Messling V, Vidal SM.

PLoS Pathog. 2013;9(4):e1003256. doi: 10.1371/journal.ppat.1003256. Epub 2013 Apr 11.

10.

The innate immune sensor NLRC3 attenuates Toll-like receptor signaling via modification of the signaling adaptor TRAF6 and transcription factor NF-κB.

Schneider M, Zimmermann AG, Roberts RA, Zhang L, Swanson KV, Wen H, Davis BK, Allen IC, Holl EK, Ye Z, Rahman AH, Conti BJ, Eitas TK, Koller BH, Ting JP.

Nat Immunol. 2012 Sep;13(9):823-31. doi: 10.1038/ni.2378. Epub 2012 Aug 5.

11.

Regulation of class I major histocompatibility complex (MHC) by nucleotide-binding domain, leucine-rich repeat-containing (NLR) proteins.

Robbins GR, Truax AD, Davis BK, Zhang L, Brickey WJ, Ting JP.

J Biol Chem. 2012 Jul 13;287(29):24294-303. doi: 10.1074/jbc.M112.364604. Epub 2012 May 29.

12.

Pathogen sensing by nucleotide-binding oligomerization domain-containing protein 2 (NOD2) is mediated by direct binding to muramyl dipeptide and ATP.

Mo J, Boyle JP, Howard CB, Monie TP, Davis BK, Duncan JA.

J Biol Chem. 2012 Jun 29;287(27):23057-67. doi: 10.1074/jbc.M112.344283. Epub 2012 May 1.

13.

NLRP12 suppresses colon inflammation and tumorigenesis through the negative regulation of noncanonical NF-κB signaling.

Allen IC, Wilson JE, Schneider M, Lich JD, Roberts RA, Arthur JC, Woodford RM, Davis BK, Uronis JM, Herfarth HH, Jobin C, Rogers AB, Ting JP.

Immunity. 2012 May 25;36(5):742-54. doi: 10.1016/j.immuni.2012.03.012. Epub 2012 Apr 12.

14.

Plexin-B2 negatively regulates macrophage motility, Rac, and Cdc42 activation.

Roney KE, O'Connor BP, Wen H, Holl EK, Guthrie EH, Davis BK, Jones SW, Jha S, Sharek L, Garcia-Mata R, Bear JE, Ting JP.

PLoS One. 2011;6(9):e24795. doi: 10.1371/journal.pone.0024795. Epub 2011 Sep 23.

15.

The Chlamydia protease CPAF regulates host and bacterial proteins to maintain pathogen vacuole integrity and promote virulence.

Jorgensen I, Bednar MM, Amin V, Davis BK, Ting JP, McCafferty DG, Valdivia RH.

Cell Host Microbe. 2011 Jul 21;10(1):21-32. doi: 10.1016/j.chom.2011.06.008.

16.

NLRX1 protein attenuates inflammatory responses to infection by interfering with the RIG-I-MAVS and TRAF6-NF-κB signaling pathways.

Allen IC, Moore CB, Schneider M, Lei Y, Davis BK, Scull MA, Gris D, Roney KE, Zimmermann AG, Bowzard JB, Ranjan P, Monroe KM, Pickles RJ, Sambhara S, Ting JP.

Immunity. 2011 Jun 24;34(6):854-65. doi: 10.1016/j.immuni.2011.03.026.

17.

Monocytic microparticles activate endothelial cells in an IL-1β-dependent manner.

Wang JG, Williams JC, Davis BK, Jacobson K, Doerschuk CM, Ting JP, Mackman N.

Blood. 2011 Aug 25;118(8):2366-74. doi: 10.1182/blood-2011-01-330878. Epub 2011 Jun 23.

18.

Discovery of a viral NLR homolog that inhibits the inflammasome.

Gregory SM, Davis BK, West JA, Taxman DJ, Matsuzawa S, Reed JC, Ting JP, Damania B.

Science. 2011 Jan 21;331(6015):330-4. doi: 10.1126/science.1199478. Erratum in: Science. 2011 Sep 23;333(6050):1703.

19.

The inflammasome NLRs in immunity, inflammation, and associated diseases.

Davis BK, Wen H, Ting JP.

Annu Rev Immunol. 2011;29:707-35. doi: 10.1146/annurev-immunol-031210-101405. Review.

20.

Cutting edge: NLRC5-dependent activation of the inflammasome.

Davis BK, Roberts RA, Huang MT, Willingham SB, Conti BJ, Brickey WJ, Barker BR, Kwan M, Taxman DJ, Accavitti-Loper MA, Duncan JA, Ting JP.

J Immunol. 2011 Feb 1;186(3):1333-7. doi: 10.4049/jimmunol.1003111. Epub 2010 Dec 29.

21.

DJ-1 enhances cell survival through the binding of Cezanne, a negative regulator of NF-kappaB.

McNally RS, Davis BK, Clements CM, Accavitti-Loper MA, Mak TW, Ting JP.

J Biol Chem. 2011 Feb 11;286(6):4098-106. doi: 10.1074/jbc.M110.147371. Epub 2010 Nov 19.

22.

Deletion of ripA alleviates suppression of the inflammasome and MAPK by Francisella tularensis.

Huang MT, Mortensen BL, Taxman DJ, Craven RR, Taft-Benz S, Kijek TM, Fuller JR, Davis BK, Allen IC, Brickey WJ, Gris D, Wen H, Kawula TH, Ting JP.

J Immunol. 2010 Nov 1;185(9):5476-85. doi: 10.4049/jimmunol.1002154. Epub 2010 Oct 4.

23.

The role of technology in facial prosthetics.

Davis BK.

Curr Opin Otolaryngol Head Neck Surg. 2010 Aug;18(4):332-40. doi: 10.1097/MOO.0b013e32833bb38c. Review.

PMID:
20543693
24.

CD28 expression redefines thymocyte development during the pre-T to DP transition.

Teague TK, Tan C, Marino JH, Davis BK, Taylor AA, Huey RW, Van De Wiele CJ.

Int Immunol. 2010 May;22(5):387-97. doi: 10.1093/intimm/dxq020. Epub 2010 Mar 4.

PMID:
20203098
25.

'Show me the money': financial incentives increase chlamydia screening rates among tertiary students: a pilot study.

Currie MJ, Schmidt M, Davis BK, Baynes AM, O'Keefe EJ, Bavinton TP, McNiven M, Martin SJ, Bowden FJ.

Sex Health. 2010 Mar;7(1):60-5. doi: 10.1071/SH08091.

PMID:
20152098
26.

NLRP3 has a sweet tooth.

Davis BK, Ting JP.

Nat Immunol. 2010 Feb;11(2):105-6. doi: 10.1038/ni0210-105. Review. No abstract available.

PMID:
20084064
27.

On mapping the genetic code.

Davis BK.

J Theor Biol. 2009 Aug 21;259(4):860-2. doi: 10.1016/j.jtbi.2009.05.009. Epub 2009 May 20. No abstract available.

PMID:
19463833
28.

C-C chemokine receptor 5 on pulmonary fibrocytes facilitates migration and promotes metastasis via matrix metalloproteinase 9.

van Deventer HW, Wu QP, Bergstralh DT, Davis BK, O'Connor BP, Ting JP, Serody JS.

Am J Pathol. 2008 Jul;173(1):253-64. doi: 10.2353/ajpath.2008.070732. Epub 2008 Jun 5.

29.

Long-term survival following salvage reirradiation with concurrent chemotherapy for recurrent head and neck cancer.

Watkins JM, Stuart RK, Davis BK, Day TA, Chaudharry UB, Sharma AK.

J S C Med Assoc. 2008 Feb;104(2):36-9. Review. No abstract available.

PMID:
18396601
30.

The NLR gene family: a standard nomenclature.

Ting JP, Lovering RC, Alnemri ES, Bertin J, Boss JM, Davis BK, Flavell RA, Girardin SE, Godzik A, Harton JA, Hoffman HM, Hugot JP, Inohara N, Mackenzie A, Maltais LJ, Nunez G, Ogura Y, Otten LA, Philpott D, Reed JC, Reith W, Schreiber S, Steimle V, Ward PA.

Immunity. 2008 Mar;28(3):285-7. doi: 10.1016/j.immuni.2008.02.005. No abstract available.

31.

Impaired thymopoiesis in interleukin-7 receptor transgenic mice is not corrected by Bcl-2.

Van de Wiele CJ, Marino JH, Tan C, Kneale HA, Weber J, Morelli JN, Davis BK, Taylor AA, Teague TK.

Cell Immunol. 2007 Nov-Dec;250(1-2):31-9. doi: 10.1016/j.cellimm.2008.01.002. Epub 2008 Mar 5.

32.

Monarch-1 suppresses non-canonical NF-kappaB activation and p52-dependent chemokine expression in monocytes.

Lich JD, Williams KL, Moore CB, Arthur JC, Davis BK, Taxman DJ, Ting JP.

J Immunol. 2007 Feb 1;178(3):1256-60.

33.

Dental aesthetics and the aging patient.

Davis BK.

Facial Plast Surg. 2006 May;22(2):154-60.

PMID:
16847807
34.

Coevolution theory of the genetic code: is the precursor-product hypothesis invalid?

Davis BK.

Bioessays. 2005 Dec;27(12):1308; author reply 1309; discussion 1310. No abstract available.

PMID:
16299768
35.

CATERPILLER: a novel gene family important in immunity, cell death, and diseases.

Ting JP, Davis BK.

Annu Rev Immunol. 2005;23:387-414. Review.

PMID:
15771576
36.

CATERPILLER 16.2 (CLR16.2), a novel NBD/LRR family member that negatively regulates T cell function.

Conti BJ, Davis BK, Zhang J, O'connor W Jr, Williams KL, Ting JP.

J Biol Chem. 2005 May 6;280(18):18375-85. Epub 2005 Feb 10.

37.

Deficiency of CD11b or CD11d results in reduced staphylococcal enterotoxin-induced T cell response and T cell phenotypic changes.

Wu H, Rodgers JR, Perrard XY, Perrard JL, Prince JE, Abe Y, Davis BK, Dietsch G, Smith CW, Ballantyne CM.

J Immunol. 2004 Jul 1;173(1):297-306.

38.

Expansion of the genetic code in yeast: making life more complex.

Davis BK.

Bioessays. 2004 Feb;26(2):111-5. Review.

PMID:
14745828
40.

Oral cancer treatment.

Day TA, Davis BK, Gillespie MB, Joe JK, Kibbey M, Martin-Harris B, Neville B, Richardson MS, Rosenzweig S, Sharma AK, Smith MM, Stewart S, Stuart RK.

Curr Treat Options Oncol. 2003 Feb;4(1):27-41. Review.

PMID:
12525277
42.

Molecular evolution before the origin of species.

Davis BK.

Prog Biophys Mol Biol. 2002 May-Jul;79(1-3):77-133. Review.

PMID:
12225777
43.

Skull base reconstruction and rehabilitation.

Day TA, Davis BK.

Otolaryngol Clin North Am. 2001 Dec;34(6):1241-57, xi. Review.

PMID:
11728944
44.

Darwinian aspects of molecular evolution at sublinear propagation rates.

Davis BK.

Bull Math Biol. 2000 Jul;62(4):675-94. Erratum in: Bull Math Biol 2000 Sep;62(5):1001.

PMID:
10938628
45.

Evolution of the genetic code.

Davis BK.

Prog Biophys Mol Biol. 1999;72(2):157-243. Review.

PMID:
10511799
46.

The forces driving molecular evolution.

Davis BK.

Prog Biophys Mol Biol. 1998;69(1):83-150. Review. Erratum in: Prog Biophys Mol Biol 1999;71(2):I-II.

PMID:
9670775
48.

Prosthetic-surgical collaborations in the rehabilitation of patients with head and neck defects.

Davis BK, Roumanas ED, Nishimura RD.

Otolaryngol Clin North Am. 1997 Aug;30(4):631-45. Review.

PMID:
9233862
49.
50.

Clinical evaluation of implants retaining edentulous maxillary obturator prostheses.

Roumanas ED, Nishimura RD, Davis BK, Beumer J 3rd.

J Prosthet Dent. 1997 Feb;77(2):184-90.

PMID:
9051607

Supplemental Content

Loading ...
Support Center